General
Preferred name
DL-Carnitine
Synonyms
LEVOCARNITINE ()
L-carnitine ()
Carnitina ()
CARNITINE ()
CS-4771 ()
(¡À)-Carnitin ()
Carnitine, dl- ()
Carnitine dl-form ()
NSC-757390 ()
Carnitine ()
P&D ID
PD055488
CAS
461-06-3
406-76-8
Tags
available
drug candidate
Drug indication
Attention deficit hyperactivity disorder
Sepsis
Drug Status
investigational
Max Phase
3.0
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
PRICE
29
DESCRIPTION
DL-Carnitine (Carnitina) is the constituent of liver and striated muscle. In therapeutically It is used to stimulate pancreatic and gastric secretions and to treat hyperlipoproteinemias.
(TargetMol Bioactive Compound Library)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
6
ChEMBL Drugs
DrugMAP
DrugMatrix
Ki Database
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
29
Molecular Weight
161.11
Hydrogen Bond Acceptors
3
Hydrogen Bond Donors
1
Rotatable Bonds
4
Ring Count
0
Aromatic Ring Count
0
cLogP
-1.81
TPSA
60.36
Fraction CSP3
0.86
Chiral centers
1.0
Largest ring
0.0
QED
0.49
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Target
O-acetyltransferase
Source data
